Literature DB >> 4803900

Intra-arterial cancer chemotherapy with combined anticancer agents.

S Fujimoto, T Miyoshi, Y Nomura, T Akao, B Ito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4803900     DOI: 10.1007/bf02469460

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


× No keyword cloud information.
  20 in total

1.  THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.

Authors:  J S EVANS; G D MENGEL
Journal:  Biochem Pharmacol       Date:  1964-07       Impact factor: 5.858

2.  CANCER CHEMOTHERAPY BY PROLONGED ARTERIAL INFUSION.

Authors:  E WATKINS; R D SULLIVAN
Journal:  Surg Gynecol Obstet       Date:  1964-01

3.  Chemotherapy of breast cancer by regional intra-arterial infusion.

Authors:  H A Freckman
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

4.  A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).

Authors:  P J Burke; A A Serpick; P P Carbone; N Tarr
Journal:  Cancer Res       Date:  1968-02       Impact factor: 12.701

5.  Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.

Authors:  J P Howard; V Albo; W A Newton
Journal:  Cancer       Date:  1968-03       Impact factor: 6.860

6.  Combination chemotherapy of metastatic testicular germinal cell tumors and soft part sarcomas.

Authors:  E M Jacobs
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

7.  Prolonged infusion of arabinosyl cytosine in childhood leukemia.

Authors:  J J Wang; O S Selawry; T J Vietti; G P Bodey
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

8.  Combination chemotherapy of acute lymphocytic leukemia of childhood.

Authors:  E S Henderson
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

9.  Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy.

Authors:  I M Ariel; G T Pack
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

10.  Clinical pharmacology and human antitumor activity of cytosine arabinoside.

Authors:  R W Talley; R M O'Bryan; W G Tucker; R V Loo
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.